×
About 255 results

ALLMedicine™ Acute Urticaria Center

Research & Reviews  83 results

Childhood Acute Urticaria and Seasonal Patterns Presenting in the Emergency Department ...
https://doi.org/10.1097/PEC.0000000000002297
Pediatric Emergency Care; Koumaki D, Koumaki V et. al.

Jan 7th, 2022 - To characterize the clinical presentation, possible trigger factors and seasonality of acute urticaria (AU) in children referred to the emergency department in a teaching hospital in London, United Kingdom. This was a retrospective descriptive stu...

The Role of Cetirizine in the Changing Landscape of IV Antihistamines: A Narrative Review.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643118
Advances in Therapy; Blaiss MS, Bernstein JA et. al.

Dec 5th, 2021 - Since 1955, the only available H1 antihistamines for intravenous administration have been first-generation formulations and, of those, only intravenously administered (IV) diphenhydramine is still approved in the USA. Orally administered cetirizin...

Modified Xiao-Feng Powder for Chronic Urticaria
https://clinicaltrials.gov/ct2/show/NCT04967092

Dec 3rd, 2021 - Urticaria is a common skin disorder and 15-25% of people experience at least one attack of urticaria during their lifetime. Urticaria can be divided into acute urticaria (AU) and chronic urticaria (CU) according to the disease duration. CU is clas...

Nutrition and urticaria.
https://doi.org/10.1016/j.clindermatol.2021.10.008
Clinics in Dermatology; Shao K, Feng H

Nov 27th, 2021 - Urticaria is a distressing dermatologic condition for many. Although the wheals of urticaria are characteristically evanescent, lasting less than 24 hours, patients tend to have recurrent episodes. Hives that last less than 6 weeks are considered ...

Acute urticaria alone after CoronaVac COVID-19 vaccination should not be a contraindica...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652927
Clinical and Experimental Dermatology; Triwatcharikorn J, Puaratana-Arunkon T et. al.

Oct 6th, 2021 - Patients who develop an immediate allergic reaction within the first 4 h of COVID-19 vaccine injection are recommended not to receive the same vaccine again. This recommendation mainly focuses on the mRNA and adenoviral vector COVID-19 vaccines, b...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  3 results

Modified Xiao-Feng Powder for Chronic Urticaria
https://clinicaltrials.gov/ct2/show/NCT04967092

Dec 3rd, 2021 - Urticaria is a common skin disorder and 15-25% of people experience at least one attack of urticaria during their lifetime. Urticaria can be divided into acute urticaria (AU) and chronic urticaria (CU) according to the disease duration. CU is clas...

Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria
https://clinicaltrials.gov/ct2/show/NCT02935699

Nov 27th, 2019 - This was a multi-center, parallel group, randomized, double-blind, active controlled, Phase III clinical trial of cetirizine injection 10 mg/mL versus diphenhydramine injection 50 mg/mL (Benadryl or generic equivalent) in approximately 256 subject...

Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in Emergency
https://clinicaltrials.gov/ct2/show/NCT02565680

May 11th, 2017 - Acute urticaria is common and affected 12% of population. 400 patients come in department emergency of Toulouse each year and there aren't many studies in literature which evaluate the glucocorticoids treatment. Acute urticaria is pruritic and inc...

see more →

News  13 results

Intravenous Cetirizine Prevents Infusion Reactions From Paclitaxel in Breast Cancer, Other Tumors
https://www.onclive.com/view/intravenous-cetirizine-prevents-infusion-reactions-from-paclitaxel-in-breast-cancer-other-tumors

Mar 22nd, 2021 - Intravenous (IV) cetirizine (Quzyttir) showed comparable efficacy to IV diphenhydramine for the prevention of infusion reactions (IRs) in patients with cancer who are undergoing treatment with an anti-CD20 antibody or paclitaxel, according to resu...

FDA OKs Cetirizine Injection (Quzyttir ) for Acute Urticaria
https://www.medscape.com/viewarticle/919911

Oct 15th, 2019 - The US Food and Drug Administration (FDA) has approved cetirizine hydrochloride for intravenous injection (Quzyttir, JDP Therapeutics) for treatment of acute urticaria in adults and children 6 months of age or older. Quzyttir will be available as ...

Fast Five Quiz: Refresh Your Knowledge on Key Aspects of Acute Urticaria
https://reference.medscape.com/viewarticle/894410_3

Mar 27th, 2018 - Cutaneous biopsy findings from urticaria lesions may be divided into the following categories, because the response to treatment may be different: Class 1: A mixture of perivascular dermal inflammatory infiltrates composed of lymphocytes, monocyte...

Fast Five Quiz: Refresh Your Knowledge on Key Aspects of Acute Urticaria
https://reference.medscape.com/viewarticle/894410_1

Mar 27th, 2018 - Urticaria (hives) is a vascular reaction of the skin marked by the transient appearance of smooth, slightly elevated papules or plaques (wheals) that are erythematous and that are often attended by severe pruritus. Individual lesions resolve witho...

Fast Five Quiz: Refresh Your Knowledge on Key Aspects of Acute Urticaria
https://reference.medscape.com/viewarticle/894410_5

Mar 27th, 2018 - Suspected food allergies can be confirmed or disproved with the use of food diaries. A food or symptom diary for a fixed duration (eg, 2-4 weeks) may be helpful. Note all activities in which the patient was involved for 6-8 hours before the onset ...

see more →